Skip to main content
Top
Published in:

Open Access 01-12-2023 | Chronic Kidney Disease | Research

Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years

Authors: Yun Cheng, Zhihui Lu, Xuesen Cao, Xiaoqiang Ding, Jianzhou Zou, Huimin Jin

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Cardiac valvular calcification (CVC) is prevalent in haemodialysis (HD) patients. Its association with mortality in Chinese incident haemodialysis (IHD) patients remains unknown.

Methods

A total of 224 IHD patients who had just begun HD therapy at Zhongshan Hospital, Fudan University, were enrolled and divided into two groups according to the detection of cardiac valvular calcification (CVC) by echocardiography. The patients were followed for a median of 4 years for all-cause mortality and cardiovascular mortality.

Results

During follow-up, 56 (25.0%) patients died, including 29 (51.8%) of cardiovascular disease. The adjusted HR related to all-cause mortality was 2.14 (95% CI, 1.05–4.39) for patients with cardiac valvular calcification. However, CVC was not an independent risk factor for cardiovascular mortality in patients who had just begun HD therapy.

Conclusion

CVC at baseline is an independent risk factor for all-cause mortality in HD patients and makes an independent contribution to the prediction of all-cause mortality. These findings support the use of echocardiography at the beginning of HD.
Literature
1.
go back to reference Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Remuzzi G, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19.CrossRefPubMed Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Remuzzi G, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19.CrossRefPubMed
2.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B, Wang H, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.CrossRefPubMed Zhang L, Wang F, Wang L, Wang W, Liu B, Wang H, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.CrossRefPubMed
3.
go back to reference Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Farmer CK, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72(1):92–9.CrossRefPubMed Stevens PE, O’Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Farmer CK, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72(1):92–9.CrossRefPubMed
4.
go back to reference Düsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Jansen F, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl). 2021;99(3):335–48.CrossRefPubMed Düsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Jansen F, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl). 2021;99(3):335–48.CrossRefPubMed
5.
go back to reference Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Tonelli M, et al. Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol. 2015;26(10):2504–11.CrossRefPubMedPubMedCentral Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Tonelli M, et al. Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol. 2015;26(10):2504–11.CrossRefPubMedPubMedCentral
7.
go back to reference Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Agodoa L, et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013;61(1 Suppl 1):A7, e1–476. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Agodoa L, et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013;61(1 Suppl 1):A7, e1–476.
8.
go back to reference Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238–52.CrossRefPubMed Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238–52.CrossRefPubMed
9.
go back to reference Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83.CrossRefPubMed Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83.CrossRefPubMed
10.
go back to reference Raggi P. Cardiovascular disease: Coronary artery calcification predicts risk of CVD in patients with CKD. Nat Rev Nephrol. 2017;13(6):324–6.CrossRefPubMed Raggi P. Cardiovascular disease: Coronary artery calcification predicts risk of CVD in patients with CKD. Nat Rev Nephrol. 2017;13(6):324–6.CrossRefPubMed
11.
go back to reference Ureña-Torres P, D’Marco L, Raggi P, García-Moll X, Brandenburg V, Mazzaferro S, et al. Valvular heart disease and calcification in CKD: more common than appreciated. Nephrol Dial Transplant. 2020;35(12):2046–53.CrossRefPubMed Ureña-Torres P, D’Marco L, Raggi P, García-Moll X, Brandenburg V, Mazzaferro S, et al. Valvular heart disease and calcification in CKD: more common than appreciated. Nephrol Dial Transplant. 2020;35(12):2046–53.CrossRefPubMed
12.
go back to reference London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol. 2000;11(4):778–83.CrossRefPubMed London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol. 2000;11(4):778–83.CrossRefPubMed
13.
go back to reference Adeney KL, Siscovick DS, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20(2):381–7.CrossRefPubMedPubMedCentral Adeney KL, Siscovick DS, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20(2):381–7.CrossRefPubMedPubMedCentral
14.
go back to reference Wang Z, Jiang A, Wei F, Chen H. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):12.CrossRefPubMedPubMedCentral Wang Z, Jiang A, Wei F, Chen H. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):12.CrossRefPubMedPubMedCentral
18.
19.
go back to reference Shuvy M, Abedat S, Eliaz R, Abu-Rmeileh I, Abu-Snieneh A, Ben-Dov IZ, et al. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease. Am J Physiol Heart Circ Physiol. 2019;317(4):H695–704.CrossRefPubMed Shuvy M, Abedat S, Eliaz R, Abu-Rmeileh I, Abu-Snieneh A, Ben-Dov IZ, et al. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease. Am J Physiol Heart Circ Physiol. 2019;317(4):H695–704.CrossRefPubMed
20.
go back to reference Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol. 2011;6(8):1920–5.CrossRefPubMedPubMedCentral Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol. 2011;6(8):1920–5.CrossRefPubMedPubMedCentral
21.
go back to reference Nakagawa N, Matsuki M, Yao N, Hirayama T, Ishida H, Kikuchi K, et al. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis. Ther Apher Dial. 2015;19(1):30–9.CrossRefPubMed Nakagawa N, Matsuki M, Yao N, Hirayama T, Ishida H, Kikuchi K, et al. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis. Ther Apher Dial. 2015;19(1):30–9.CrossRefPubMed
22.
go back to reference Toyoda K, Kuragano T, Kawada H, Taniguchi T, Nakanishi T. Effect of Progression in Malnutrition and Inflammatory Conditions on Adverse Events and Mortality in Patients on Maintenance Hemodialysis. Blood Purif. 2019;47(Suppl 2):3–11. https://doi.org/10.1159/000496629. Epub 2019 Apr 3 PMID: 30943483.CrossRefPubMed Toyoda K, Kuragano T, Kawada H, Taniguchi T, Nakanishi T. Effect of Progression in Malnutrition and Inflammatory Conditions on Adverse Events and Mortality in Patients on Maintenance Hemodialysis. Blood Purif. 2019;47(Suppl 2):3–11. https://​doi.​org/​10.​1159/​000496629. Epub 2019 Apr 3 PMID: 30943483.CrossRefPubMed
23.
go back to reference Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D. Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS ONE. 2014;9(5):e97565.CrossRefPubMedPubMedCentral Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D. Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS ONE. 2014;9(5):e97565.CrossRefPubMedPubMedCentral
26.
go back to reference Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, et al. Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study. Circulation. 2017;135(21):2081–3.CrossRefPubMed Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, et al. Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study. Circulation. 2017;135(21):2081–3.CrossRefPubMed
27.
go back to reference De Vriese AS, Caluwé R, Pyfferoen L, De Bacquer D, De Boeck K, Delanote J, et al. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study. J Am Soc Nephrol. 2020;31(1):186–96.CrossRefPubMed De Vriese AS, Caluwé R, Pyfferoen L, De Bacquer D, De Boeck K, Delanote J, et al. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study. J Am Soc Nephrol. 2020;31(1):186–96.CrossRefPubMed
Metadata
Title
Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years
Authors
Yun Cheng
Zhihui Lu
Xuesen Cao
Xiaoqiang Ding
Jianzhou Zou
Huimin Jin
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03076-7

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more